Taxotere (docetaxel) is being launched for advanced breast cancer

July 1996

Taxotere (docetaxel) is being launched for advanced breast cancer...by Rhone-Poulenc Rorer.

Taxotere is similar to Taxol (paclitaxel)...it works as well as Taxol for anthracycline-resistant breast cancer. But it causes severe neutropenia, hypersensitivity reactions, and fluid retention.

Watch for significant drug interactions in patients on Taxotere. It's metabolized by the same cytochrome P450 liver enzyme (CYP3A4) as terfenadine (Seldane), ketoconazole, erythromycin.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote